Contact
Please use this form to send email to PR contact of this press release:
Valneva Receives Marketing Authorization in Europe for the World’s First Chikungunya Vaccine, IXCHIQ®
TO:
Please use this form to send email to PR contact of this press release:
Valneva Receives Marketing Authorization in Europe for the World’s First Chikungunya Vaccine, IXCHIQ®
TO: